Commodities

Technical Analysis – WTI crude oil stabilizes after vaccine boost

Posted on November 19, 2020 at 9:00 am GMT

Christina Parthenidou, XM Investment Research Desk

WTI crude oil futures (December delivery) crawled above its 20- and 50-day simple moving averages (SMA) following the positive vaccine news, but the 61.8% Fibonacci of the 65.61 – 6.62 downleg appeared heavy to push once again at 43.08, with the price stabilizing around that level.

The tiny thin candles posted the past few days mirror an indecisive market. Still, with the RSI attempting to regain strength above its 50 neutral mark and the MACD gradually rising within the positive area, hopes for more bullish action remain.

The region above the 43.00 level is obstacle-free until the 48.80 number, a break of which could immediately get trapped within the former 50.60 – 53.90 restrictive area.

On the downside, if the bears retake control, the 50-day SMA could add some footing around 40.00 as it did last week. Diving lower, the 200-day SMA and the 38.2% Fibonacci of 36.13 could stop the sell-off from testing the swing low of 33.63 as any violation at this point would re-activate the downtrend from the 43.76 peak. If the latter materializes, selling interest may pick up steam towards the 38.2% Fibonacci of 29.17 and the 27.80 barrier.

Summarizing, WTI crude oil is in a sideways move between the 40.00 and 43.00 boundaries. Any break at these borders would steer the commodity in a new direction.

oil

Legal disclaimer: The material does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instruments. XM accepts no responsibility for any use that may be made of these comments and for any consequences resulting in it. No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. The research and analysis does not involve any specific investment objectives, financial situation and needs of any specific person who may receive it.

It has not been prepared in accordance with legal requirements designed to promote the independence of research, and as such it is considered to be marketing communication. Although we are not specifically constrained from dealing ahead of the publication of our research, we do not seek to take advantage of it before we provide it to our clients. We aim to establish, maintain and operate effective organisational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients. We operate a policy of independence, which requires our employees to act in our clients’ best interests and to disregard any conflicts of interest in providing our services.

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losing all of your invested capital, so please make sure that you fully understand the risks involved.